Pharsight

ALNYLAM PHARMACEUTICALS patents facing oppositions

Top patents of ALNYLAM PHARMACEUTICALS facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3366775B1 27 Apr, 2022 Modified rnai agents Nov, 2032 1
EP3656860B1 20 Apr, 2022 Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Jun, 2032 1
EP3105331B1 23 Jun, 2021 Ketohexokinase (khk) irna compositions and methods of use thereof Feb, 2035 1
EP2723758B1 20 Jun, 2018 Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof NA 1